Copanlisib plus nivolumab shows microsatellite-stable colorectal cancer activity in phase 1/2
A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...
A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine